Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP001139

Drug Information
NameLevomethadyl Acetate    
SynonymsBIDD:PXR0155; D04716; LS-74438; DB01227; 3-Heptanol, 6-(dimethylamino)-4,4-diphenyl-, acetate (ester), (3S,6S)-(-)- (8CI); 34433-66-4; Levacetylmethadolum; alpha-(-)-Acetylmethadol; Benzeneethanol, beta-((2S)-2-(dimethylamino)propyl)-alpha-ethyl-beta-phenyl-, acetate (ester), (alphaS)-; DEA No. 9648; Benzeneethanol, beta-[(2S)-2-(dimethylamino)propyl]-alpha-ethyl-beta-phenyl-, acetate (ester), (alphaS)- (9CI); CHEBI:6441; MolPort-004-285-956; AC1L2582; AC1Q5X3P; 1-alpha-Acetylmethadol; Levomethadyl acetate (USAN); LS-187090; Benzeneethanol, beta-(2-(dimethylamino)propyl)-alpha-ethyl-beta-phenyl-, acetate (ester), (S-(R*,R*))-; levo-Alphacetylmethadol; LAAM; C08012; Orlaam; BIDD:GT0373; Levomethadyl acetate; [(3S,6S)-6-(dimethylamino)-4,4-diphenylheptan-3-yl] acetate; a-l-acetylmethadol; levo-alpha-Acetylmethadol; [S-(R*,R*)]-beta-[2-Dimethylamino)propyl]-alpha-ethyl-beta-phenylbenzeneethanol acetate (ester); 3-HEPTANOL, 6-(DIMETHYLAMINO)-4,4-DIPHENYL-, ACETATE (ester), (3S,6S)-(-)-; levo-Methadyl acetate; benzeneethanol, beta-[(2S)-2-(dimethylamino)propyl]-alpha-ethyl-beta-phenyl-, acetate (ester), (alphaS)-; Levacetylmethadol; Levacetylmethadol (INN); l-alpha-Acetylmethadol; Benzeneethanol, beta-[2-(dimethylamino)propyl]-alpha-ethyl-beta-phenyl-, acetate (ester), [S-(R*,R*)]-; Levacetilmetadol [INN-Spanish]; Levacetylmethadolum [INN-Latin]; N-alpha-Acetylmethadol; 1477-40-3; CHEMBL1514; (-)-6-(Dimethylamino)-4,4-diphenyl-3-heptanol acetate (ester); (1S,4S)-4-(dimethylamino)-1-ethyl-2,2-diphenylpentyl acetate; Benzeneethanol, beta-(2-(dimethylamino)propyl)-alpha-ethyl-beta-phenyl-, acetate (ester), (-)-; CID15130; Levomethadyl; alpha-l-Acetylmethadol; Levacetylmethadol [INN]; (3S,6S)-6-(dimethylamino)-4,4-diphenylheptan-2-yl acetate; (-)-alpha-Acetylmethadol; Levacetilmetadol    
Trade NameOrlaam    
CompanyRoxane Laboratories    
IndicationOpiate dependenceApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAnalgesics    
CAS NumberCAS 1477-40-3
PubChem Compound IDCID 15130.    
PubChem Substance IDSID 10212.    
SuperDrug ATC IDN07BC03;    
SuperDrug CAS ID001477403;    
TargetMu-type opioid receptorAgonist[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 020315 To Reference
Ref 2Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann N Y Acad Sci. 2000;909:186-216. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543